Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxlovid for Post-Acute COVID-19 Syndrome (PROLIFIC)
NCT05823896Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2023
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Nirmatrelvir in post acute COVID-19 syndrome, sponsored by Karolinska Institutet. Started May 2023; status: completed.
02
Drugs
Nirmatrelvir
03
Conditions
post acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT05823896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823896.